Unity Biotechnology, Inc. Long-term Debt, Gross
Unity Biotechnology, Inc. had Long-term Debt, Gross of $18.33 million as of 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentCarryingAmount · last filed 2023-08-08
- 2023-06-30: Long-term Debt, Gross $18.33M.
- 2023-03-31: Long-term Debt, Gross $21.56M.
- 2022-12-31: Long-term Debt, Gross $21.56M.
- 2022-09-30: Long-term Debt, Gross $21.56M.
| Period end | Long-term Debt, Gross |
|---|---|
| 2023-06-30 | $18.33M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $21.56M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $21.56M 10-K · filed 2023-03-15 |
| 2022-09-30 | $21.56M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $21.56M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $21.56M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $24.26M 10-K · filed 2022-03-15 |
| 2021-09-30 | $26.56M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $26.56M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $26.56M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $26.56M 10-K · filed 2021-03-23 |
| 2020-09-30 | $26.56M 10-Q · filed 2020-11-04 |